The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Clinical trial NCT02253394 · TERMINATED
Trial details
- NCT number
- NCT02253394
- Sponsor
- Brigham and Women's Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2018-02-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.